Financhill
Back

Y-mAbs Therapeutics Vs. Rapid7 Industry Stock Comparison

Sell
35

YMAB
Y-mAbs Therapeutics

Last Price:
11.59
Seasonality Move:
11.04%
Sell
41

RPD
Rapid7

Last Price:
38.66
Seasonality Move:
14.39%
Sell
35
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics a Buy, Sell or Hold?

  • The current Y-mAbs Therapeutics [YMAB] share price is $11.60. The Score for YMAB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Rapid7 (RPD) is a Sell

Is Rapid7 a Buy, Sell or Hold?

  • The current Rapid7 [RPD] share price is $38.11. The Score for RPD is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RPD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

YMAB Stock Price Chart

What is Y-mAbs Therapeutics's stock price today?

  • The Y-mAbs Therapeutics share price today is $11.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.

RPD Stock Price Chart

What is Rapid7's stock price today?

  • The Rapid7 share price today is $38.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPD is experiencing selling pressure, which indicates risk of future bearish movement.

YMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 30.78 Sell
Chaikin Money Flow: -233807 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.81 - 16.39) Sell
Bollinger Bands (100): (10.42 - 16.82) Sell

RPD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.6 Sell
Relative Strength Index (14 RSI): 30.39 Sell
Chaikin Money Flow: -575860 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.61 - 46.33) Sell
Bollinger Bands (100): (45.39 - 57.47) Sell

YMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.3 Sell
20-day SMA: 14.49 Sell
50-day SMA: 14.96 Sell
200-day SMA: 9.6 Buy
8-day EMA: 12.64 Sell
20-day EMA: 13.84 Sell
50-day EMA: 14.33 Sell
200-day EMA: 11.25 Buy

RPD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.2 Sell
20-day SMA: 42.6 Sell
50-day SMA: 46.58 Sell
200-day SMA: 50.68 Sell
8-day EMA: 39.34 Sell
20-day EMA: 41.84 Sell
50-day EMA: 45.89 Sell
200-day EMA: 49.88 Sell

Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.29 per share.

Rapid7 Earnings Growth & RPD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.02 per share, an increase this year of $0.88 per share, and an increase next year of $0.19 per share.

Y-mAbs Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapid7 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):